Inogen (INGN) Reports Q1 EPS of 11c, Maintains Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Stifel Raises Price Target After Inogen (INGN) Reports Better-Than-Expected 1Q
May 10, 2016 9:48 AM EDTStifel reiterated a Buy rating on Inogen, Inc (NASDAQ: INGN), and raised the price target to $52.00 (from $46.00), following the company's 1Q earnings report. INGN reported revenue of $43m, ahead of the consensus estimate of ~$41.7m. The strongest contributor to growth was the domestic business-to-business channel.... More
Inogen, Inc (INGN) Product Cycle Is More Important Than EBITDA Miss - Needham & Company
May 10, 2016 6:25 AM EDTNeedham & Company analyst, Mike Matson, thinks there is a buying opportunity after Inogen, Inc (NASDAQ: INGN) beat consensus revenue but missed consensus EBITDA in 1Q16. Management maintained 2016 guidance but the analyst upped his PT to $58 based on 5x 2017 sales.
Domestic business-to-business... More
